1. Home
  2. WEYS vs ALDX Comparison

WEYS vs ALDX Comparison

Compare WEYS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

N/A

Current Price

$30.06

Market Cap

280.9M

ML Signal

N/A

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$5.51

Market Cap

336.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEYS
ALDX
Founded
1906
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.9M
336.3M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
WEYS
ALDX
Price
$30.06
$5.51
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
20.8K
722.4K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
3.63%
N/A
EPS Growth
N/A
N/A
EPS
2.54
N/A
Revenue
$279,843,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$63.48
P/E Ratio
$11.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.51
$1.14
52 Week High
$38.24
$7.20

Technical Indicators

Market Signals
Indicator
WEYS
ALDX
Relative Strength Index (RSI) 49.55 58.41
Support Level $28.69 $4.70
Resistance Level $30.73 $5.35
Average True Range (ATR) 1.35 0.29
MACD -0.12 0.07
Stochastic Oscillator 37.48 78.17

Price Performance

Historical Comparison
WEYS
ALDX

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: